Evaluation of bebtelovimab for COVID-19 treatment
October 25, 2022
Research has shown that using bebtelovimab to treat COVID-19 in an outpatient setting has been associated with lower odds of hospitalization or death, particularly among immunocompromised and older patients.... Read More >>